Tagged: Cervarix

GSK’s Cervarix Vaccine…


http://www.dailystar.co.uk/news/latest-news/593546/hpv-cervical-cancer-vaccine-teenager-dancer-paralysed-jab

Teen dancer left paralysed after HPV cervical cancer vaccine

A TEENAGE dancer has been left paralysed from the waist down after taking the HPV vaccine which helps to prevent cervical cancer.

Chloe Brookes-Holder and her mother SWNS

TRAGIC: A teen dancer has been left paralysed after taking the HPV vaccine

Chloe Brookes-Holder was once a healthy 12-year-old who danced six days a week when given the jab.

But now, six years on, the 18-year-old remains stranded in hospital, emaciated and paralysed.

Chloe, of Cheltenham, Gloucestershire, said: “At first, my family and I didn’t put two and two together.

Chloe Brookes-Holder on a hospital bed SWNS

PARALYSED: Chloe Brookes-Holder remains stranded in hospital

“Since getting sick from something the NHS gave me I don’t trust any medical professionals that I don’t know”

Chloe Brookes-Holder

“We thought the vaccine was safe because they give it in schools and on the letter the parents were given to sign consent I remember reading ‘it saves lives’.”

She said in the months that followed getting the injection at school, she fell ill with dizziness, headaches, fatigue and bone and joint pain – which left her muscles weakened.

She has now lost three stones, dropping to just 5st and is now being fed through a tube.

For years, doctors told Chloe the condition was in her head but now some believe the injection triggered an autoimmute response, causing her body to attack itself.

The teen said: “We trust our government to keep us safe but now, since getting sick from something the NHS gave me I don’t trust any medical professionals that I don’t know.

“Why? Because I’ve been treated in such a barbaric way. It’s been ill on earth.”

Chloe Brookes-Holder in hospital SWNS

STRANDED: The 18-year-old is left paralysed from the waist down

Shocking photos show her hooked to wires and drips, as she lies in a hospital – where she has been for the past 11 months.

Her mother, Sophie Brookes, 41, has been forced to give her job up as a hairdresser to become her full-time carer.

The 18-year-old is certain her symptoms are linked to the vaccine, which protects against the human papilloma virus and cause cervical caner – this kills around 900 women a year.

Chloe Brookes-Holder in hospital SWNS

VACCINE: She has now lost three stones and is being fed through a tube

She said: “I danced six days a week and loved to go to after-school sport and dance clubs every night. I was on the right road to getting A’s at GCSE.

“I wanted to have a dance career and my heart bleeds with the torture knowing I may never walk again and therefore ever dance again.”

Parents have called for more research into the jab, which has been a routine offered to 12 and 13-year-old girls since 2008.

Chloe became ill between her second and third injection of the Cervarix vaccine in late 2010 and the summer of 2011.

She came down with a string of viruses, started experiencing debilitating muscle pain and was diagnosed with fibromyalgia.

A gastrointestinal disorder left her in agony every time she ate or lost control of her bladder.

Chloe Brookes-Holder before she became paralysed SWNS

ONCE A UPON A TIME: Chloe was once a healthy 12-year-old

She was later diagnosed with Postural Orthostatic Tachycardia Syndrome which causes abnormal heart rate.

A year after having the injection, Chloe also began experiencing paralytic episodes and collapsing at school, unable to control her lower body.

She said: “I’m not scaremongering, I just care about others. This is real. This is the pure ugly truth. I want to make people aware so they can make decisions for themselves.”

Chloe Brookes-Holder in hospital SWNS

SHOCKING: Photos show her hooked to wires and drips

Cervarix was given to 6 million girls and while it is no longer offered to girls at school by the NHS, a new HPV vaccine, Gardasil is.

European Medicines Agency statistics show that up to January 2017, 3,683 reactions to Cervarix were reported and 11,802 to Gardasil.

Some 380 families, represented by the UK Association for Vaccine Injured Daughters, have called for more information in schools and research into potential side effects.

Medics have dismissed their concerns and NHS England insists that the jab is not dangerous, writing on its website that it is a “safe vaccine”.

Freda Burrell, of the UK Association for Vaccine Injured Daughters, said: “Many medical professionals will not link the vaccine to the girls’ health problems.

“Yet common sense should speak loudly if their medical records were excellent prior to the vaccine and their health changed dramatically after they had the jab.”

Chloe Brookes-Holder with her mother Sophie SWNS

LOVE: Her mum has been forced to give up her job to become her full-time carer

Public Health England and the Medicines and Healthcare products Regulatory Agency issued a joint statement in response to the claims.

They said: “As with all vaccines, the safety of the HPV vaccine is under constant review. Every report of a suspected side effect is taken seriously.”

“That there is no credible evidence of a link between the HPV vaccine and a range of chronic illnesses.”

They concluded: “The European Medicines Agency has also rued out a link to Postural Orthostatic Tachycardia Syndrome.”

2 Comments
2 Comments

11 days ago
SteveHinks
In 2008 the UK Government, assuming that the HPV vaccine to be capable of preventing cervical cancer (without any evidence to support it can prevent a single case of cancer), did an Impact Assessment using £1.7 billion as the cost of using HPV vaccine for the next 100 years. They also failed to consider any cost of adverse reactions! even though there were huge numbers during the clinical trials.

11 days ago
SteveHinks

There is ZERO evidence that Cervarix and Gardasil will ever prevent a single case of cancer. The manufacturers, GSK and Merck, only ever state they are ‘intended to’ or ‘expected to’ but it will be 20 years before we find out.

Cervarix is expected to prevent 2 strains of HPV, Gardasil 4 strains and Gardasil9 9 strains but there are over 170 strains of HPV with at least 40 involved in cancers but scientists expect other strains, potentially more lethal, to take the place of those which might be prevented by the vaccines.

The World Health Organisation has a database of adverse drug reports at vigiaccess.org. There are over 72,000 reports of adverse events with this vaccine, including 280 deaths, WHO also acknowledges only 10% get reported.

What is worse there have been several reports of VACCINATED girls as young as 18 developing cervical cancer.

Thank you Chloe for being so brave and helping to out the truth about this awful vaccine which is costing taxpayers hundreds of millions of pounds and filling our hospitals with severely disabled patients.

If you suspect your daughter, or son, have developed serious autoimmune diseases following vaccination please contact the UK Association of HPV Vaccine Injured Daughters (AHVID) for help


http://www.japantimes.co.jp/news/2017/02/13/national/crime-legal/suit-opens-tokyo-court-cervical-cancer-vaccine-side-effects/

/

Suit opens in Tokyo court over cervical cancer vaccine side effects

by

Staff Writer

Twenty-eight girls and women suffering what they say are side effects from cervical cancer vaccines that were recommended by the government demanded compensation from the state and drugmakers Monday as their trial opened at the Tokyo District Court.

The plaintiffs, ranging in age from 15 to 22, said they have experienced a wide range of health problems, including pain all over their bodies and impaired mobility, after receiving the human papillomavirus (HPV) vaccines between 2010 and 2013.

Each is demanding ¥15 million in damages.

Erina Sonoda, a 20-year-old college student, said she started to suffer strong menstrual pain after receiving the second of three recommended shots of the Cervarix vaccine, and the pain spread to other parts of her body after the third vaccination.

Due to agonizing pain, Sonoda said she has difficulty walking without a cane and often must use a wheelchair.

“I felt acute pain as if someone was squashing my internal organs. … Such conditions have only gotten worse,” Sonoda told the court while sitting in a wheelchair.

“I received the shots because the government recommended it,” she said. “I want the government to take seriously its responsibility for causing us (to suffer from) such symptoms.”

Since last July, a total of 119 plaintiffs have filed similar suits with courts in Tokyo, Nagoya, Osaka and Fukuoka, according to Masumi Minaguchi, a lawyer representing the women.

The government and the drugmakers — GlaxoSmithKline PLC and Merck Sharp & Dohme Corp., who make the HPV vaccines Cervarix and Gardasil, respectively — sought Monday to dismiss the compensation claims.

Representatives of the drugmakers said the safety and effectiveness of the medicines against cervical cancer have been scientifically confirmed and denied there is any link between the alleged side effects and the vaccines.

The Health, Labor and Welfare Ministry began recommending in April 2013 that girls between 12 and 16 be vaccinated for cervical cancer. But the ministry halted the recommendation two months later following reports of side effects.

According to the ministry, 2,945 people out of the 3.39 million women who had received the shots by the end of last April have reported side effects.

A causal link between the HPV vaccines and reported symptoms remains unclear, and no scientific proof has been submitted.

A nationwide survey conducted by a health ministry research team between July and December 2015 found symptoms claimed as side effects of cervical cancer vaccines in both vaccinated and unvaccinated populations.

The team is conducting further detailed analysis of the data.

Cervical cancer is the second most common cause of cancer deaths in women under 40. Each year about 10,000 women develop the disease in Japan and around 2,900 die annually, according to the National Cancer Center.

The primary cause of cervical cancer is human papillomavirus, a common infection transmitted through sexual intercourse. The cervical cancer vaccines are believed to help prevent HPV.

In December 2015, the World Health Organization issued a statement criticizing the government’s decision to cease recommending the vaccine, saying that “policy decisions based on weak evidence, leading to lack of use of safe and effective vaccines, can result in real harm.”

GSK Pulls Cervarix From The US Market..


http://www.fiercepharma.com/pharma/gsk-exits-u-s-market-its-hpv-vaccine-cervarix

 

GSK exits U.S. market with its HPV vaccine Cervarix

GSK

Japanese Women Seek Justice For Damage From GSK’s Cervarix (Cervical Cancer Vaccine).


http://www.asahi.com/ajw/articles/AJ201607280028.html

945-million-yen lawsuit filed over cervical cancer vaccines

THE ASAHI SHIMBUN

July 28, 2016 at 14:00 JST

Photo/IllutrationPlaintiffs and their supporters head to Tokyo District Court on July 27 to submit a mass lawsuit related to side effects from cervical cancer vaccines. (Naoko Kawamura)

Sixty-three young women are seeking a combined 945 million yen ($9 million) in compensation in the first mass lawsuit concerning side effects from cervical cancer vaccines.

The women are suing the central government and pharmaceutical companies GlaxoSmithKline Plc and MSD KK.

The lawsuits were filed July 27 in the district courts at Tokyo, Osaka, Nagoya and Fukuoka. The plaintiffs are aged between 15 and 22.

The women argue they have suffered health problems, such as pain in various parts of their bodies, difficulty in walking and also impaired eyesight, as a result of taking the vaccines that were meant to prevent cervical cancer.

They were mostly in junior or senior high school when they took the vaccines between July 2010 and July 2013.

The vaccines under question are GSK’s Cervarix, which was approved for domestic use in 2009, and MSD’s Gardasil, which was approved in 2011.

The plaintiffs argue that reports had been filed overseas where the two vaccines were in use before Japan about various side effects, including cases of death and serious illness.

The women claim the central government bears responsibility for approving the vaccines and recommending their use without adequately looking into safety concerns despite knowing about the possible dangers.

The lawsuit argues that a legal causal relationship exists because common symptoms appeared among the plaintiffs after taking the vaccines.

According to officials at the health ministry, about 3.4 million women have taken the vaccines. As of the end of April, some 2,900 reports had been submitted by medical facilities and the pharmaceutical companies that indicated possible side effects. Of those cases, 1,600 were considered serious.

“We would like to refrain from commenting,” said a health ministry official with regard to the lawsuit. “We believe it is important to provide support while being there for those who are suffering.”

A GSK spokesperson declined comment on the grounds the company had not yet received a copy of the lawsuit.

MSD released a statement that said the company plans to submit evidence in court.

(This article was written by Seiko Sadakuni and Tomoyo Fukumiya.)

Glaxo In Developing Countries: GSK’s Indian Guinea Pig Kids…


REP GLAXO

It’s interesting to note that GSK were named as one of RepRisk’s most controversial companies in 2013. That’s 5 years after CEO Andrew Witty took the helm and promised that all of GSK’s bad behavior was from ‘another era’. This fabled era which Witty keeps harping on about perhaps relates to GSK’s illegal an unethical behavior under Witty’s predecessor JP Garnier.

However, Andrew Witty was a high ranking corporate executive during JP’s reign and has been with GSK since 1985, therefore it’s kind of puzzling that he would try to allude that GSK’s unethical behavior has nothing at all to do with him or his leadership, surely as an employee of some 40 years, Witty would have some knowledge of what GSK get up to?

Furthermore, even after GSK settled a 3 Billion dollar fine (from the brave and courageous whistle-blowing claims of previous GSK employee Greg Thorpe) in 2012- which apparently were to put an end to GSK’s corruption and bribery era- they were still named as one of the most controversial companies of 2013. They attained this accolade from their various ethical and moral transgressions such as a half a billion dollar fine (and sentencing of GSK staff from) their vast bribery network uncovered in China and US office of fair trading accusations in relation to Seroxat and Wellbutrin violations etc, in 2013.

One of the most disturbing aspects of the RepRisk report is Glaxo’s testing of vaccines on young girls in India-

See the following links for more on this-

http://www.pharmaceutical-technology.com/news/newsgsk-msd-accused-of-conducting-illegal-vaccine-trials-on-indian-girls

GSK, MSD accused of conducting illegal vaccine trials on Indian girls

0

8 January 2013

Gardasil

Indian activists have accused GlaxoSmithKline and MSD Pharmaceuticals of conducting illegal tests of their HPV vaccines on tribal girls in Andhra Pradesh and Gujarat.

The Supreme Court said on Monday that the local activists filed a public interest litigation (PIL) alleging that the companies tested two unproven HPV vaccines designed to prevent cervical cancer – gardasil and cervarix – on 24,000 girls, including 44 patients at the Maharaja Yeshwantrao Hospital.

Of these 44 patients tested, 10 were male, said the report.

The Times of India reports that the PIL, filed by Kalpana Mehta of Indore, Nalini Bhanot and V Rukmini Rao representing Gramya Resource Centre for Women, alleges that the testing led to adverse effects on the girls’ health.

Seven girls allegedly died during the vaccine trial.

Justice S Radhakrishnan and Justice Dipak Misra have directed the Union government to immediately file its reply on the issue.

The Christian Medical College, Vellore, has also been asked by the apex court to examine the medical records of the girls in question.


November 18, 2013 9:13 am

Vaccination scandal taints reputation of India drug trials

About 72,000 Indian women die each year of cervical cancer, a disease caused by the human papillomavirus. Many of these deaths are preventable by vaccines already widely used in the US, Australia and Europe, and included in their recommended immunisation protocols.

In 2009, Path, a US-based health charity, launched a project funded by the Bill and Melinda Gates Foundation to study the cost and feasibility of incorporating HPV vaccines, produced by Merck and GlaxoSmithKline, into India’s public sector immunisation programme.

However, the programme to vaccinate 14,000 adolescent girls from poor families ran into trouble after seven died soon after their vaccinations. The ensuing media and political storm – highlighting sensitivities around drug trials in the developing world – has contributed to the restrictions on such studies, affecting both Indian and global pharmaceutical companies.

The causes of the girls’ deaths were never established or conclusively linked to the HPV vaccine. But serious questions were raised over whether the participants’ parents – many of whom were illiterate – had given informed consent, and whether the project adequately tracked any adverse reactions.

In August, an Indian parliamentary committee set up to probe the issue concluded the Path project was a clinical trial in all but name and that the organisation had used “subterfuge” to avoid the “arduous and strictly regulated process” of such a trial.

The committee report said many of the girls’ consent forms had apparently been signed by school principals and hostel wardens, and expressed scepticism that the girls’ parents were fully briefed on the pros and cons.

The committee also found there was no rigorous process to track adverse events, leading to “gross underreporting”. It came down hard on Indian government agencies for alleged dereliction of duty.

“The safety and rights of the children in this vaccination project were highly compromised and violated,” the report said.

It also claimed that Path’s “sole aim was to promote the commercial interests of HPV vaccine manufacturers, who would have reaped windfall profits had Path been successful in getting the HPV vaccine included” in India’s immunisation protocols.

Path called the parliamentary report an “inaccurate characterisation of this important work” and said it disagreed with its “findings, conclusions and tone”.

The organisation said the HPV project was driven by its belief that “poor and low-income girls in India should not be deprived of the right or access to this proven, life-saving and safe vaccine that wealthy and middle-class girls in India and around the world have access to through the private market and other public immunisation programmes”.


Home GlaxoSmithKline accused of illegally administering vaccines leading to the death of children in India

http://www.australiannationalreview.com/indian-sc-raps-government-inaction-illegal-drug-testing/

GlaxoSmithKline accused of illegally administering vaccines leading to the death of children in India

Apr 4, 2016

 By: Atreyee Chowdhury

 

drug testing
The Indian Supreme Court has sought answers from the government in a case involving tribal children, who were allegedly inducted into a drug trial without their consent years ago, and died because of the consequent reactions. The court criticised inaction on the government’s part and gave it a month’s time to respond.

Some children out of a group of selected children died after being injected with Merck’s Gardasil vaccine. The vaccine is manufactured by GlaxoSmithKline.

According to some campaigners, a study, promoted by Bill and Melinda Gates Foundation, failed to obtain consent from children or their parents before they were administered with the drug. The allegations, if proved, would mean that the drug companies conducted an illegal drug trial on the children.

The petitioners also asked judges to look into the way trials were conducted with Merck’s new cervical cancer vaccine, Gardasil 9. Research by MailOnline, revealed that some children showed abnormal symptoms after they were administered the drug. Gardasil 9, is expected to generate £1.2 billion a year in sales.

The Indian Council of Medical Research (ICMR) had in 2010, asked state governments to suspend the cervical cancer control vaccination programme for girls after four deaths and complications among 120 girls were reported. The girls complained of stomach disorders, epilepsy, headaches and early menarche.

An investigation by an Indian parliamentary committee had previously concluded that the trials amounted to a serious breach of trust and medical ethics. Merck and GSK have both been ordered to respond to the allegations made by campaigners.

After taking into consideration the arguments from campaigners, the judges also ordered the government to produce an opinion on the issue of liability and compensation, which was welcomed by lawyers.

Speaking to Daily Mail, Kerry McBroom, one of the lawyers, said, ‘It is a very encouraging development that the judges are now discussing accountability and not just accountability but also compensation, so the tone of the hearing today was very positive for us because it’s clear from all the parties, including from government reports, that there were, at best, serious irregularities and, at worst, gross violations of fundamental human rights.’

The court expressed its unhappiness that the government had not come out with concrete action following the parliamentary committee’s findings. It gave the government a month to explain what action had been taken to investigate and what efforts had been made to obtain the consent of those taking part in the trials.

Gardasil is a drug that is used to prevent cervical cancer, which is the second most common type of cancer in women and kills more than 265,000 people every year according to Cancer Research UK.

 

…there are no significant data showing that either Gardasil or Cervarix (GlaxoSmithKline) can prevent any type of cervical cancer…


http://preventdisease.com/news/16/022416_HPV-Vaccine-Rate-Lowest-Participation-Since-Inception.shtml

FEBRUARY 24, 2016 by DAVE MIHALOVIC

HPV Vaccine Rate At Lowest Participation, Dropping More Than 50 Percent Since The Inception of The Program


Vaccination rates are steadily decreasing worldwide, and as more parents now become informed of one of the most unscientific vaccines in the history of vaccination, the HPV vaccine uptake is now dropping more than 50 percent since its introduction in 2006.

Two centuries of UK, USA and Australian official death statistics have shown conclusively and scientifically that modern medicine is not responsible for and played little part in substantially improved life expectancy and survival from disease in western economies.

The fact that many vaccines are ineffective is becoming increasingly apparent. Just a few years ago, Merck was slapped with two separate class action lawsuits contending they lied about the effectiveness of the mumps vaccine in their combination MMR shot, and fabricated efficacy studies to maintain the illusion for the past two decades that the vaccine is highly protective.

A summary review of data on neurological adverse events and the historical role of vaccination in the natural course of infectious disease in Switzerland and Germany, supports data from other regions with evidence that vaccines had no impact on disease prevention efforts from the early-mid to late 20th century.

On the results of analyses of specific outbreaks, some epidemiologists have confirmed on the that out of the cases investigated, that 97 percent of the children were vaccinated.

Convincing evidence has been highlighted in peer reviewed studies showing that the rapid increase in the number of vaccines given to children is creating synergistic toxicity and a state of immune overload in the majority of vaccine recipients manifesting in related health issues including epidemics of obesity, diabetes, and autism.

HPV – A Vaccine Based On Junk Science and Fraud

A publication in the Annals of Medicine has exposed the fraudulent nature of Human papillomavirus (HPV) vaccines such as Gardasil and Cervarix. That’s not a big surprise to most advocates in the natural health community, since no vaccine has ever been fully evaluated in humans to assess long-term health risks. HPV vaccines are no exception.

The problem is, vaccinations such as HPV are not preventative, they do compromise safety and physicians will never provide accurate explanations of vaccine risks and benefits because they do not know themselves. Physicians can only rely on the information from vaccine manufacturers and since long-term pharmacokinetic effects which study the bodily absorption, distribution, metabolism and excretion of vaccines and their ingredients are never examined or analyzed, a Physician can never fully inform of patient of ANY benefits or risks.

In many countries, for a consent to be legally valid if risks and benefits have been explained to the individual. This includes adequate information on which patients can base their decision on whether to accept or refuse a vaccine. In most cases, it requires having a full explanation of the vaccine risks and side-effects.

At present there are no significant data showing that either Gardasil or Cervarix (GlaxoSmithKline) can prevent any type of cervical cancer since the testing period employed was too short to evaluate long-term benefits of HPV vaccination. The longest follow-up data from phase II trials for Gardasil and Cervarix are 5 and 8.4 years, respectively, while invasive cervical cancer takes up to 20 -40 years to develop from the time of acquisition of HPV infection.

Current worldwide HPV immunization practices with either of the two HPV vaccines appear to be neither justified by long-term health benefits nor economically viable, nor is there any evidence that HPV vaccination (even if proven effective against cervical cancer) would reduce the rate of cervical cancer beyond what Pap screening has already achieved.

Cumulatively, the list of serious adverse reactions related to HPV vaccination worldwide includes deaths, convulsions, paraesthesia, paralysis, Guillain-Barre syndrome (GBS), transverse myelitis, facial palsy, chronic fatigue syndrome, anaphylaxis, autoimmune disorders, deep vein thrombosis, pulmonary embolisms, and cervical cancers.

The number of children in private health plans getting vaccinated for HPV is declining by staggering numbers.

Citing low demand, high costs – and questioning the benefits, Utah’s Public Department of Health banned the vaccine. “The backlash and sentiment against it was strong enough that there’s no reason to go there,” physician David Blodgett explained. “No one wants it and it’s too expensive when we’re not funded to provide it.”

At 42 percent, Utah ranks lowest in the nation for completion of the three-injection series among girls who start it. “Some national estimates are showing that HPV vaccination participation has dropped more than 50 percent across the nation since the program was introduced in 2006,” said infectious disease specialist Dr. Alla Anosov.

Decline Continues In HPV Vaccine Completion Rate Thanks To Informed Parents

Thanks to the wealth of information available on the HPV vaccine fraud, the proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly — as much as 63 percent — since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston.

The study, published in Cancer, revealed the steepest decline in vaccine completion among girls and young women aged nine to 18 — the age group according to medical officials that should receive the vaccine in three doses over six months — a message that has been drilled into parents for just over five years. It’s a sign that parents are listening and completing their own research on the dangers of HPV vaccination despite Doctor’s recommendations.

Crippling Adverse Effects

Mercola reports on 213 women who took Gardasil and suffered permanent disability. Multiple-sclerosis-like symptoms and neurological complications, including seizures, paralysis and speech problems, are being reported by increasing numbers of girls and women following Gardasil vaccination

A class-action lawsuit was filed in Australia against drug maker Merck by a young woman who suffered autoimmune and neurological health problems following injections with the HPV vaccine, Gardasil

Between May 2009 and September 2010, 16 deaths occurred after Gardasil vaccination, along with 789 reports of “serious” adverse reactions; 213 cases of permanent disability; and 25 cases of Guillain Barre Syndrome. Between September 1, 2010 and September 15, 2011, yet another 26 deaths were reported.

In 2013, Japan’s health ministry issued a nationwide notice that cervical cancer vaccinations should no longer be recommended for girls due to several hundred adverse reactions to the vaccines reported.

What Are The Facts?

Consider some of the facts related to cervical cancer and the HPV vaccine:

  • Cervical cancer is not a major health issue for women under good gynecological care.
  • HPV vaccines may protect against four strains of high-risk HPV but the duration of effectiveness is not clear; best estimates to date are from 4 to 6 years
  • HPV vaccination does not eliminate the need for traditional cervical cancer screening
  • Prior exposure to vaccine-relevant strains of HPV can increase the risk of cancer by 44.6% if injected with Gardasil and 32.5% if injected with Cervarix
  • HPV is not transmitted solely via sexual contact, there are multiple other ways to have been exposed
  • There are already well over 300 reports to VAERS of abnormal pap smears post-vaccination
  • HPV does not cause cervical cancer, it is the persistant infection, not the virus, that determines the risk
  • 93% of women initially infected with a particular strain of HPV will not show the same strain four menstrual cycles later
  • Most cervical cancer deaths in the United States, and developed countries, are people who are not under regular OB/GYN care.
  • The National Cancer Institute has no data on which HPV genotypes are prevalent in the United States.
  • A CDC study showed that HPV types 16 and 18, the two HPV vaccine-relevant strains, are NOT the prevalent types in American women.
  • Three published papers on HPV prevalence in the U.S., indicated that types 62, 84 and 52 are the most prevalent. None of these are targeted in either approved HPV vaccine, and type 52 is an accepted high-risk “carcinogenic” strain of HPV.
  • If a person has prior exposure to vaccine-relevant HPV prior to injection, the vaccine provides no benefit, but does provide potential risks.
  • If a woman is infected with HPV-16 in January, HPV-18 in July, and HPV-31 in December, her cancer risk is zero. Even though these are all high risk types, they are considered transient. It takes repeated infection by the same type to perhaps pose a risk of cervical cancer.
  • Even when a woman has persistant infection by the same type, if her lifestyle is healthy (she does not smoke, does not take oral contraceptives, does not have multiple sexual partners, does not have a compromised immune system) her risk of cervical cancer is still minimal.
  • HPV is not necessarily a sexually transmittable virus–you can get it other ways.
  • American women currently spend $10 billion on unnecessary colposcopies (cervical biopsies) every year, primarily because the currently used HPV tests frequently display false positive results.
  • A study conducted by Harvard School of Public Health estimated that 95% of cervical biopsies in the United States are not necessary.
  • If a young woman is considering taking an HPV vaccine, it is critical that she know if she has been exposed to HPV, and if so, what genotype.
  • Nothing has been proven to be more effective at controlling cervical cancer than pap smear technology.
  • To date, the efficacy of HPV vaccines in preventing cervical cancer has not been demonstrated, while vaccine risks remain to be fully evaluated.
  • Current worldwide HPV vaccination practices with either of the two HPV vaccines appear to be neither justified by long-term health benefits nor economically viable, nor is there any evidence that HPV vaccination (even if proven effective against cervical cancer) would reduce the rate of cervical cancer beyond what Pap screening has already achieved.
  • Cumulatively, the list of serious adverse reactions related to HPV vaccination worldwide includes cervical cancer itself.
  • The almost exclusive reliance on manufacturers sponsored studies, often of questionable quality, as a base for vaccine policy-making should be discontinued.
  • the presentation of partial and non-factual information regarding cervical cancer risks and the usefulness of HPV vaccines, as cited above, is neither scientific nor ethical.

The presentation of partial and non-factual information regarding cervical cancer risks and the usefulness of HPV vaccines, as cited above, is neither scientific nor ethical. None of these practices serve public health interests, nor are they likely to reduce the levels of cervical cancer. Independent evaluation of HPV vaccine safety is urgently needed and should be a priority for government sponsored research programmes. Any future vaccination policies should adhere more rigorously to evidence-based medicine as well as strictly follow ethical guidelines for informed consent.

Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.

GSK.. Famous In China For All The Wrong Reasons…


“…Mr Gisserot said GSK’s vaccines business would be its strongest source of growth in coming years, highlighting the potential of its Cervarix jab to protect young women from cervical cancer…”

GSK are famous in China.. for all the wrong reasons…

That’s according to GSK’s new head of their China division (the replacement for the scandalous Mark Reilly ) – Hervé Gisserot..

I wonder when GSK will atone all the Seroxat damage that they caused to many thousands of us?…

I won’t hold my breath… considering one of Hervé’s drugs he aims to push on the Chinese is GSK’s Cervarix...

Cervarix is proving to be yet another controversial GSK drug but that won’t stop GSK and Hervé Gisserot pushing it in the new Chinese market will it?..

The side effects from Cervarix have been leaking out in the media since 2009, see the Telegraph for more:

Cervarix: the simple injection causing so much controversy

The cervical cancer jab Cervarix is currently under scrutiny after nearly 1,500 Britons have experienced adverse reactions to it.

Carly Steele has not felt right since receiving the cervical cancer vaccine, Cervarix - Cervarix: the vaccine causing so much controversy

Carly Steele has not felt right since receiving the cervical cancer vaccine, Cervarix Photo: RII SCHROER

Amanda Steele first noticed a change in her daughter Carly last summer. The normally exuberant 13-year-old had lost all of her energy. Whereas normally she would have spent her days outside on the trampoline, she now found it difficult to leave the sofa. It was even a struggle to walk unaided to the bathroom.

 

The blackouts, when they came, were more worrying. Mother would find daughter out cold on the floor of their Stockport home. Every joint in Carly’s body ached, and simple tasks such as washing her hair became impossible. Carly, on the brink of womanhood, suddenly seemed more like a toddler. It is six months now since she last attended school.

 

“It is like the light has gone out in her eyes,” says her mother. “It is absolutely heartbreaking to watch.”

 

At first, the doctors blamed vertigo. Then came a diagnosis of the balance disorder Labyrinthitis. Next, ME was suggested. Amanda is not convinced any of these conditions are implicated. What she believes is that Carly’s condition is related to the cervical cancer vaccine she received last year.

 

“The doctors all look at me like I am an idiot when I bring up the possibility of the jab having this effect on her, but she was a healthy, happy girl before she had it and now she isn’t, and I simply can’t believe that it has nothing to do with it.”

This week, relief of sorts arrived for the Steele family in the shape of a government report detailing the 1,340 instances of adverse reactions to the vaccine, Cervarix. Some girls have suffered paralysis, others convulsions; and some, like Carly, have experienced sight problems (in addition, Carly has now developed severe heat intolerance). Nausea, muscle weakness, fever, dizziness and numbness have also been reported.

 

Last updated: November 26, 2015 1:08 pm

GSK confident of China renaissance

 

GlaxoSmithKline has predicted a return to growth in China next year as it slowly begins to repair the damage from a corruption scandal which shattered the company’s reputation in one of the world’s most important pharmaceuticals markets.

In the most detailed account yet of its recovery efforts in China, GSK said it had rooted out the bribery that resulted in a record Rmb3bn ($488m) Chinese fine and halted the haemorrhaging of sales that has shrunk the business by more than a fifth.

Hervé Gisserot, GSK’s general manager in China, forecast renewed growth from this much-diminished base next year but said he had no desire to rekindle the breakneck expansion that led the company into crisis.

“We added a floor every year without making sure the building had the foundation to be sustainable,” he said. “My job now is to make sure the foundations are fit for future growth.”

Mr Gisserot admitted that GSK had become famous in China “for the wrong reasons” after being found guilty last year of what prosecutors described as “massive and systematic bribery” of doctors and health officials to boost prescriptions of its drugs.

But he promised to put the company at the forefront of efforts to clean up the Chinese pharmaceuticals market — behind only the US in size — after a radical overhaul of its sales and marketing model to reduce the risk of corruption.

The pharma model in China is not sustainable . . . others will have to adjust– Hervé Gisserot, GSK’s general manager in China

Measures include severing the link between sales and remuneration for GSK sales representatives, no longer paying doctors for speaking on the company’s behalf, and a ban on cash reimbursement for entertainment expenses.

Mr Gisserot warned that other companies risked punishment by Chinese authorities if they failed to follow GSK’s reforms. “I cannot believe GSK is a one off. This anti-corruption [drive] will continue. I hope others will learn before it is too late.”

GSK’s revenues in China fell 23 per cent between 2012 and 2013 and its sales force dropped from 5,000 to 3,000 as doctors shunned the company in the wake of the scandal. But the business has since stabilised and remains profitable.

Herve Gisserot©AFP

Hervé Gisserot, GSK’s general manager in China

After a modest upturn next year, Mr Gisserot predicted more “dynamic” growth from 2017 but said the days of double-digit annual expansion in the Chinese drugs market were over as the government tries to drive down prices. “The pharma model in China is not sustainable . . . others will have to adjust.”

Mr Gisserot said GSK’s vaccines business would be its strongest source of growth in coming years, highlighting the potential of its Cervarix jab to protect young women from cervical cancer.

China represented less than 3 per cent of GSK’s global sales last year at about £580m but is a strategically important part of the wider push by Sir Andrew Witty, chief executive, to tap rising demand for healthcare in the developing world.

%d bloggers like this: